Market Data Forecast

Autoimmune Diagnostics Market to Thrive Owing to Increasing Autoimmune Disorders

The Global Autoimmune diagnostics Market was worth $13.07 billion in 2016 and estimated to reach $15.6 billion by the end of 2021 with a growing potential of 3.6%.


Hyderabad, India -- (SBWIRE) -- 02/09/2018 -- Market Data Forecast has announced the addition of the "Autoimmune Diagnostics Market by Test type - (Autoantibody Tests, Antinuclear Antibody Tests, Complete Blood Count (CBC), C - reactive protein (CRP), Comprehensive Metabolic panel, Urinalysis, Erythrocyte Sedimentation Rate (ESR) and others), by Disease - (Localized auto immune disease diagnostics, Systemic auto immune disease diagnostics) by End users - (Hospitals, Research centers, diagnostic laboratories) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)", is published by Market Data Forecast report to their offering. The Autoimmune Diagnostics Market was valued to be worth $13.07 billion in 2016 and expected to grow at a CAGR of 3.6% to approach $15.6 billion by the end of 2021."

The Autoimmune disease occurs only when the immune system attacks the healthy cells of the body by considering them as foreign cells. The malfunctioning of the system is because of the failure to recognize immune cells, tissues and organs. The disease causes abnormal organ growth and changes in organ functionalities.

The most common autoimmune diseases include systemic lupus erythematosus, Hashimoto's thyroiditis, Graves' disease, multiple sclerosis, rheumatoid arthritis, type1 diabetes. There is no permanent cure for these diseases except the available relieving treatments. The autoimmune diseases are identified by performing some tests such as complete blood counts, antinuclear protein test, protein test, and a few others.

View Report Page:
Autoimmune Diagnostics Market: Drivers and Challenges
Increasing awareness about autoimmune disorders among people, growing healthcare expenditure is projected to demand the growth of the market. Other major factors attributing the market growth are increasing technological advancements coupled with improvement in laboratory techniques and increase in the prevalence of autoimmune diseases across the globe. Governments' support in order to promote the awareness about autoimmune diseases is boosting the market growth. However, lack of skilled experienced surgeons, increase in the demand for innovative technological products are hindering the growth of the market.

Request For Sample@

The Global Autoimmune Diagnostics Market is divided into end-users, test type, and disease type. On the idea of end-users, the Autoimmune Diagnostics Market is segregated into diagnostic laboratories, Hospitals, Research centres. On the origin of disease type, the market is classified as systemic autoimmune disease diagnostics, and Localized autoimmune disease diagnostics. The systemic autoimmune disease diagnostics sub-segment is further classified as Ankylosing Spondylitis, Rheumatoid Arthritis (RA), and Systemic Lupus Erythematosus (SLE). The Rheumatoid Arthritis (RA) accounts the largest share of the market owing to the Rheumatoid Arthritis (RA) occurs at any age. The Localized autoimmune disease diagnostics sub-segment is categorized as Psoriasis, Graves's disease, Multiple Sclerosis, Hashimoto's Thyroiditis, Type 1 diabetes, and others.
On the basis of test type, the Autoimmune Diagnostics Market is bifurcated into Erythrocyte Sedimentation Rate (ESR), Autoantibody Tests, C - reactive protein (CRP), Antinuclear Antibody Tests, Urinalysis, Complete Blood Count (CBC), Comprehensive Metabolic panel, and others.

Customized Report:

Regional Overview
Geographically, The Global market for Autoimmune Diagnostics is segmented into Europe, and Asia-Pacific and the Middle-East and Africa regions, North America. North America dominated the worldwide market owing to increase in the prevalence of autoimmune diseases. North America is followed by Europe and the Asia Pacific, where Asia-Pacific is expected to experience huge growth rate within the forecast period.

The prominent firms of the Autoimmune Diagnostics Market are Quest Diagnostics, Siemens Healthcare, Roche Diagnostics SQI Diagnostics, Beckman Coulter Inc., Bio-Rad, Glaxosmithkline Plc, AESKU Diagnostics, Abbott Laboratories, Eli lilly, INOVA Diagnostics Inc., Hemagen Diagnostics, Crescendo Bioscience, BioMerieux SA.

Scope of the report
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

Contact Info:
Name: Mr. Abhishek Shukla
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626